12:00 AM
Jan 09, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Synta completes follow-on

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass.
Business: Cancer, Autoimmune
Date completed: 1/6/12...

Read the full 37 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >